Mobilization of Microbiota Commensals and Their Bacteriocins for Therapeutics.


Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
08 2019
Historique:
received: 20 12 2018
revised: 12 03 2019
accepted: 19 03 2019
pubmed: 17 4 2019
medline: 1 7 2020
entrez: 17 4 2019
Statut: ppublish

Résumé

With the specter of resurgence of pathogens due to the propagation of antibiotic-resistance genes, innovative antimicrobial strategies are needed. In this review, we summarize the beneficial aspects of bacteriocins, a set of miscellaneous peptide-based bacterium killers, compared with classical antibiotics, and emphasize their use in cocktails to curb the emergence of new resistance. We highlight that their prey spectrum, their molecular malleability, and their multiple modes of production might lead to specific and personalized treatments to prevent systemic disorders. Complementarily, we discuss how we might exploit prevailing bacterial commensals, such as Streptococcus salivarius, and deliberately mobilize their bacteriocin arsenal 'on site' to cure multiresistant infections or finely reshape the endogenous microbiota for prophylaxis purposes.

Identifiants

pubmed: 30987817
pii: S0966-842X(19)30071-X
doi: 10.1016/j.tim.2019.03.007
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacteriocins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

690-702

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Pascal Hols (P)

Biochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, 1348 Louvain-la-Neuve, Belgium.

Laura Ledesma-García (L)

Biochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, 1348 Louvain-la-Neuve, Belgium.

Philippe Gabant (P)

Syngulon, rue du Bois Saint-Jean 15/1, 4102, Seraing, Belgium.

Johann Mignolet (J)

Biochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, 1348 Louvain-la-Neuve, Belgium; Syngulon, rue du Bois Saint-Jean 15/1, 4102, Seraing, Belgium. Electronic address: jmignolet@syngulon.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH